Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MBF Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
MBF Therapeutics

MBF Therapeutics

Angel

MBF Therapeutics: Innovating cancer care for animals through advanced veterinary immunotherapies.

HQ
Ambler, PA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize veterinary medicine, MBF Therapeutics focuses on advancing cancer care for companion animals through innovative immunotherapeutic products. The company's vision is to set new standards in animal healthcare by leveraging cutting-edge scientific research and technology. MBF Therapeutics offers a range of advanced veterinary immunotherapies designed to treat various forms of cancer in pets, aiming to improve both the quality and longevity of animal lives.

MBF Therapeutics has attracted notable investors and experts in veterinary medicine and biotechnology, contributing to its rapid growth and development. The company has achieved significant milestones, including successful clinical trials and regulatory approvals for its products. By pioneering new treatments in veterinary oncology, MBF Therapeutics has made a substantial impact on the field, offering hope and improved outcomes for pets diagnosed with cancer.

MBF Therapeutics - Similar Companies

Vetmab Biosciences logo

Vetmab Biosciences

Vetigenics logo

Vetigenics

vetigenics.com

Curelab Veterinary logo

Curelab Veterinary

MBX Biosciences logo

MBX Biosciences

mbxbio.com

MBC Pharma logo

MBC Pharma

mbcpharma.com

WayPath Pharma logo

WayPath Pharma

waypathpharma.com

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Pelican Therapeutics logo

Pelican Therapeutics

Mobius Therapeutics logo

Mobius Therapeutics

LTZ Therapeutics logo

LTZ Therapeutics

Animal Life Sciences logo

Animal Life Sciences

Elias Animal Health logo

Elias Animal Health

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Imvaq Therapeutics logo

Imvaq Therapeutics

Angarus Therapeutics logo

Angarus Therapeutics

angarustx.com

MBF Therapeutics - Quick Facts

Who are MBF Therapeutics' competitors?

Companies similar to MBF Therapeutics include Vetmab Biosciences, Vetigenics, Curelab Veterinary and MBX Biosciences.

When was MBF Therapeutics founded?

MBF Therapeutics was founded in 2008.

Where is MBF Therapeutics' headquarters located?

MBF Therapeutics' headquarters is located in Ambler, PA, US.

When was MBF Therapeutics' last funding round?

MBF Therapeutics' most recent funding round was for $256k (USD) in December 2021.

How much has MBF Therapeutics raised to-date?

As of Dec 21, 2021, MBF Therapeutics has raised a total of $851k (USD).

How many employees does MBF Therapeutics have?

MBF Therapeutics has 7 employees as of Feb 5, 2024.

MBF Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Veterinary Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified